← back to search

Liqiang Song

Wenzhou Medical University · CN
Area of research
Physiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer research, Cardiac fibrosis, Gene knockdown, Fibrosis, Diabetic cardiomyopathy, and Cardiac function curve.
h-index
citations
99
works
3
NIH funding
primary concept
email

Recent publications

Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial
Signal Transduction and Targeted Therapy 2025cited by 4position: middledoi
LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis
Biology Direct 2022cited by 53position: middledoi
Crenolanib, a PDGFR inhibitor, suppresses lung cancer cell proliferation and inhibits tumor growth in vivo
OncoTargets and Therapy 2014cited by 40position: middledoi
Lung metastasis of pancreatic carcinoma is regulated by TGFβ signaling
Tumor Biology 2014cited by 6position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

De Chang · National Taiwan University Hospital1 papers (2014–2014) · 1 papers (2014–2014)Lang Hu · Shanghai Medical College of Fudan University1 papers (2022–2022)Ping Wang · Henan University of Economic and Law1 papers (2014–2014)Feng Zhang · Eye & ENT Hospital of Fudan University1 papers (2022–2022)Di Wang · Qingdao Agricultural University1 papers (2022–2022)Pu-le Jin · Hebei Medical University1 papers (2014–2014)Jing Shen · Shandong University1 papers (2014–2014)Yifang Jiang · Ningbo University1 papers (2014–2014)Kailong Li · Nankai University1 papers (2014–2014)Yu Tian · Shandong University of Traditional Chinese Medicine1 papers (2014–2014) · 1 papers (2022–2022)Wenxia Hu · Hebei Medical University1 papers (2014–2014) · 1 papers (2014–2014)Hong‐Zhen Du · Hebei Medical University1 papers (2014–2014)Hyung J. Chun · Yale University1 papers (2022–2022) · 1 papers (2022–2022)Nan Geng · Hebei Medical University1 papers (2014–2014)Yan Li · South China Agricultural University1 papers (2022–2022)Dong Guo · Zhejiang Chinese Medical University1 papers (2022–2022)